Frontiers in Oncology

Immunotherapy for Brain Tumors⁣

Michael Lim, MD⁣ ⁣
Tuesday, September 15, 2020⁣ ⁣

Dr. Michael Lim is Professor and Chair of Neurosurgery at Stanford University School of Medicine. Dr. Lim obtained his medical degree from the Johns Hopkins University School of Medicine. He then completed his residency in Neurosurgery at Stanford and went on to become a Professor of Neurosurgery, Oncology and Radiation Oncology at Johns Hopkins before returning to Stanford. Dr. Lim’s surgical interest is in both benign and malignant brain tumors, with a particular interest in gliomas (including ependymoma), meningioma, pituitary tumors and skull base tumors. He has extensive experience in new and innovative neurosurgical techniques including image guided surgery, microsurgery, minimally invasive procedures and endoscopic surgery.

Dr. Lim’s primary research interest is developing immune-based therapies against brain tumors. His research laboratory is focused on understanding the mechanisms of immune evasion by primary brain tumors. Findings from his laboratory are directed towards translation to novel therapies against brain tumors. He currently serves as the principal investigator of several large brain tumor immunotherapy clinical trials based on findings from his laboratory. ⁣

Frontiers in Oncology

Frontiers in Oncology, a recurring seminar series organized by the Stanford Cancer Institute, is designed to highlight innovations in cancer research across the spectrum of basic, translational, clinical and population science.  The dynamic speakers represent a broad range of disciplines and expertise from both Stanford faculty and national thought leaders.  The audience for this seminar series includes Stanford faculty, trainees and staff as well as anyone in the broader community with an interest in cancer research.  Each recorded seminar is approximately 1 hour in length.